These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23236531)

  • 21. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD; Katoch VM
    Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug therapy (MDT) and leprosy control.
    Noordeen SK
    Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
    [No Abstract]   [Full Text] [Related]  

  • 23. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI; Colorado CL; Torres JF; León CI
    Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clofazimine-resistant M. leprae.
    Levy L
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):137-40. PubMed ID: 3519801
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multi-drug resistant Mycobacterium leprae from patients with leprosy].
    Maeda S
    Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):227-33. PubMed ID: 15508725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system.
    Franzblau SG
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2115-7. PubMed ID: 2694952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
    Hastings RC; Richard V; Christy SA; Morales MJ
    Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium leprae by bioluminescence assay (ATP method)].
    Yamazaki T; Gidoh M; Matsuoka M
    Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):227-37. PubMed ID: 17037377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy.
    Gunawan H; Sasmojo M; Putri HE; Avriyanti E; Hindritiani R; Suwarsa O
    Int J Mycobacteriol; 2018; 7(2):152-155. PubMed ID: 29900892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of rifampin, clofazimine, and B1912 on the viability of Mycobacterium leprae in established mouse footpad infection.
    Holmes IB; Banerjee DK; Hilson GR
    Proc Soc Exp Biol Med; 1976 Apr; 151(4):637-41. PubMed ID: 772686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 34. An attempt to induce a histological ENL symptom in M. leprae infected nude mice.
    Subowo
    Nihon Rai Gakkai Zasshi; 1986; 55(4):173-85. PubMed ID: 3323158
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative in vitro activities of rifamycin analogues against Mycobacterium leprae.
    Dhople AM
    Indian J Lepr; 1997; 69(4):377-84. PubMed ID: 9474513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
    Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
    Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of ATP assay for in vitro drug screening testing against human derived M. leprae.
    Katoch VM; Katoch K; Shivannavar CT; Sharma VD; Patil MA; Bharadwaj VP
    Indian J Lepr; 1989 Jul; 61(3):333-44. PubMed ID: 2671179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chemotherapy of leprosy. Part 1.
    Ellard GA
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium leprae promotes triacylglycerol de novo synthesis through induction of GPAT3 expression in human premonocytic THP-1 cells.
    Tanigawa K; Hayashi Y; Hama K; Yamashita A; Yokoyama K; Luo Y; Kawashima A; Maeda Y; Nakamura Y; Harada A; Kiriya M; Karasawa K; Suzuki K
    PLoS One; 2021; 16(3):e0249184. PubMed ID: 33770127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.